Tradeweb Markets Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$2.08B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TW stock price vs DNB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DNB's multiple
Needs DNB P/E.
Implied fair value · at TW's multiple
Needs Annual EPS is negative, TW P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Tradeweb Markets Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Dun & Bradstreet Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Intercontinental Exchange, Inc.
TW vs ICE
NASDAQ, INC.
TW vs NDAQ
CME GROUP INC.
TW vs CME
SCHWAB CHARLES CORP
TW vs SCHW
Robinhood Markets, Inc.
TW vs HOOD
EQUIFAX INC
TW vs EFX
FAIR ISAAC CORP
TW vs FICO
TransUnion
TW vs TRU
Root, Inc.
TW vs ROOT
Xerox Holdings Corp
TW vs XRX
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TW can sustain its 18.9% revenue growth and 15.7% ROIC, then TW looks preferable to DNB because it combines materially better profitability with a much cleaner balance sheet despite the incomplete valuation data.
The dataset does not provide a usable market-relative valuation comparison because TW has a P/E of 26.6x but DNB has no P/E, and the implied price is N/A. TW is trading inside its stated historical band at $100.50 versus a $90.45-$110.55 range, which suggests it is not obviously stretched on the provided range.
Supporting Metrics